Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1 Interventional

An Investigational Drug (CAL) Versus Zoledronic Acid (Zometa®) in Patients With Breast Cancer

ClinicalTrials.gov ID: NCT00051779

Public ClinicalTrials.gov record NCT00051779. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 9:18 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 24-Week Blinded Study Conducted at Multiple Centers, Evaluating the Safety and Effectiveness of Various Doses of the Investigational Drug (CAL) Versus Zoledronic Acid (Zometa®) When Randomly Assigned to Patients With Breast Cancer That Has Metastasized to Bone

Study identification

NCT ID
NCT00051779
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1
Lead sponsor
Chugai Pharma USA
Industry
Enrollment
Not listed

Conditions and interventions

Interventions

  • CAL Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Not listed
Primary completion
Not listed
Completion
Not listed
Last update posted
Jun 23, 2005

United States locations

U.S. sites
38
U.S. states
23
U.S. cities
35
Facility City State ZIP Site status
University of Arkansas for Medical Sciences Little Rock Arkansas 72205
Highlands Oncology Group Springdale Arkansas 72764
Bay Area Cancer Research Group Concord California 94520
California Cancer Care, Inc. Greenbrae California 94904
Institute of Cancer Therapies Los Angeles California
San Diego Cancer Research Institute Vista California 92083
Anschutz Cancer Pavilion at the University of Colorado Cancer Center Aurora Colorado 80010-0510
Yale University New Haven Connecticut 06520-8028
Holy Cross Hospital Fort Lauderdale Florida 33308
Rush Cancer Institute Chicago Illinois 60612-3824
University of Kentucky Medical Center Lexington Kentucky 40536-0098
Louisiana State University New Orleans Louisiana 70112-2278
Frederick Memorial Hospital Frederick Maryland 21701
Dana-Farber/Harvard Cancer Center Boston Massachusetts 02115
Josephine Ford Cancer Center Detroit Michigan 48202
Spectrum Health Grand Rapids Michigan 49503
Southfield Oncology Institute, Inc. Southfield Michigan 48076
St. Louis Center for Clinical Research St Louis Missouri 63128
Nevada Cancer Center Las Vegas Nevada 89109
Dartmouth Hitchcock Medical Center Lebanon New Hampshire 03756
New Mexico Cancer Care Associates Santa Fe New Mexico 87505
HemOnCare, P.C. Brooklyn New York 11235
Memorial Sloan Kettering Cancer Center New York New York 10021
SUNY Upstate Medical University Syracuse New York 12310
Montefiore Medical Center The Bronx New York 10467-2490
Duke University Medical Center Durham North Carolina 27710
Ireland Cancer Center Cleveland Ohio 44106
University Hospitals of Cleveland Cleveland Ohio 44106
Hematology Oncology Consultants, Inc. Columbus Ohio 43235
Penn State Hershey Medical Center Hershey Pennsylvania 17033
Palmetto Health Columbia South Carolina 29203
Boston Baskin Cancer Group Memphis Tennessee 38104
The Boston Baskin Cancer Group Memphis Tennessee 38104
The West Clinic Memphis Tennessee 38120
Cancer Specialists of South Texas, PA Corpus Christi Texas 78412
Center for Oncology Research & Treatment Dallas Texas 75230
Baylor College of Medicine Houston Texas 77030
Medical College of Wisconsin-FMLH East Neoplastic Diseases and Related Disorders Milwaukee Wisconsin 53226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00051779, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 23, 2005 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00051779 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →